arXiv:2606. 08305v1 Announce Type: cross Abstract: Externally controlled survival trials are increasingly used when concurrent randomized controls are infeasible, particularly in oncology and rare-disease settings with time-to-event endpoints.
By Se Yoon Lee, Yonghyun Kwon, Jae Kwang Kim
arXiv:2608. 00271v1 Announce Type: cross Abstract: A wide range of statistical and machine learning methods have been proposed for survival analysis with competing risks, where the occurrence of one event (i.
By Bego\~na B. Sierra, Colin McLean, Peter S. Hall, Sarah Friedrich-Welz, Catalina A. Vallejos
arXiv:2606. 03689v1 Announce Type: cross Abstract: Survival Analysis (SA) is a statistical framework that models the time span until some event of interest occurs.
By Mariana Vargas Vieyra
arXiv:2601. 22259v2 Announce Type: replace Abstract: While tabular foundation models have achieved remarkable success in classification and regression, adapting them to model time-to-event outcomes for survival analysis is non-trivial due to right-censoring, where data observations may end before the event of interest occurs.
By Da In Kim, Wei Siang Lai, Kelly W. Zhang
arXiv:2606. 12006v1 Announce Type: cross Abstract: Predicting time-to-event outcomes such as mortality is a fundamental task in clinical decision-making, commonly addressed through survival analysis.
By Minh-Khoi Pham, Luca Cotugno, Alina Sirbu, Tai Tan Mai, Martin Crane, Marija Bezbradica
arXiv:2606. 23871v1 Announce Type: new Abstract: Survival analysis is central to clinical decision-making, yet reliable time-to-event models require large, diverse cohorts that are rarely available at a single institution, while privacy regulations restrict the centralization of patient data.
By Natalia Moreno-Blasco, Anusha Ihalapathirana, Pekka Siirtola, Miguel Fernandez-de-Retana